Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

the clinical laboratory

CPI Lab Fee Adjustment Threatened by New Bill

CEO SUMMARY: Once again, the laboratory testing industry has been singled out as a healthcare “whipping boy” by Congressional aides. In working to develop the next federal budget, legislators again propose to deny annual CPI price updates for laboratory tests. This won’t be anything…

Read More



THE DARK REPORT’S Annual Ranking of Public Laboratory Companies

Boom times continued during 2001 for both the clinical laboratory industry and anatomic pathology profession. Throughout 2001, almost every public lab company was able to post double-digit revenue growth. For a number of companies, this growth was accomplished b…

Read More



Why Can’t Hospital Laboratories Collaborate?

MOST PEOPLE KNOWLEDGEABLE ABOUT THE INNER WORKINGS of the clinical laboratory industry generally agree that hospital laboratories possess inherent advantages over commercial laboratories—anytime a hospital lab outreach program is organized properly and marketed professionally. Certainly the manage…

Read More



Pathology Part A Comp Under Attack by Both Hospitals and Insurers

CEO SUMMARY: In steadily-growing numbers, hospitals and insurers are taking active steps to reduce or eliminate compensation for clinical pathology professional services, also commonly referred to as “Part A” services. Unfortunately, many pathology groups fail to anticipate this situati…

Read More



Lab Automation Subject Of “How To” Program

CEO SUMMARY: Mastering lab automation is more difficult than it appears. The first-ever “Lab Automation Boot Camp” is assembling experienced lab administrators who have experience (and scars) in automation and are committed to telling the real story about making automation successful….

Read More



Patent Access Limits Rapid HIV Testing in USA

CEO SUMMARY: Diagnostic manufacturers will begin to face the same controversy over public access to diagnostic testing technology that has dogged pharmaceutical companies in recent years. Public health officials and the military are unhappy with how Bio-Rad and its HIV-2 licensees have fa…

Read More



2001’s Ten Big Stories Presage Future Direction

CEO SUMMARY: During 2001, few labs found themselves under intense pressure to change or react to dramatic events in the healthcare marketplace. Like 2000, this past year was marked by evolutionary progress, not revolutionary change. However, continuing signs indicate that consumers will p…

Read More



Beckman Coulter Positions Itself For Biotech Testing Continuum

CEO SUMMARY: Here’s a little-known side to diagnostics giant Beckman Coulter Inc. Its efforts to expand into the fields of biomedical R&D and clinical research is a strategic shift designed to give it early access to promising technology that could be introduced into the clinical di…

Read More



Nation’s Anthrax Cases Bring Bioterror to Labs

CEO SUMMARY: America’s clinical laboratories are soon to be enlisted in the war against terrorism. Concerns about chemical and biological terrorist attacks have reached high levels following the death of a Florida man from pulmonary anthrax and the discovery of letters containing anthra…

Read More



“September 24, 2001 Intelligence: Late Breaking Lab News”

Many different professions lost good people as a result of the terrorist attack on the World Trade Center in New York City on September 11. However, the clinical laboratory industry and the pathology profession seems to have emerged unscathed. Following many conversations with laboratorians throughou…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;